AGCO reported third-quarter 2026 net sales of $2.3 billion, down 8.6% from a year earlier, with adjusted earnings of $1.05 per share versus $1.35 in the third quarter of 2025. It also gave a full-year 2026 adjusted EPS outlook of about $5.50 and projected 2026 net sales of $9.8 billion to $10.0 billion, citing the weakest global industry demand in more than a decade.
Q3 2026 net sales were $2.3 billion, down 8.6%; Europe/Middle East sales fell 19.1% and Latin America fell 15.4%
Reported EPS was $0.75 versus $4.09 a year earlier, which included gains from 2025; adjusted EPS was $1.05 versus $1.35
Full-year 2026 adjusted EPS outlook is about $5.50, with adjusted operating margin projected at about 7.0%
Nine-month 2026 adjusted EPS was $3.42 versus $3.11 in the same period of 2025, while nine-month net sales rose 0.7%
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From AGCO's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$10.08B
-13.5%
$9.75
—
7.2%
FY2024
$11.66B
-19.1%
$-5.69
-136.4%
-3.6%
FY2023
$14.41B
+13.9%
$15.63
+31.7%
8.1%
FY2022
$12.65B
+13.6%
$11.87
+0.2%
7.0%
FY2021
$11.14B
+21.7%
$11.85
+109.7%
8.1%
Frequently asked questions
When is AGCO's next earnings date?
AGCO has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did AGCO earn last quarter?
For the quarter ended Sep 2026, AGCO reported diluted EPS of $0.75 (-81.7% year over year) on revenue of $2.26B (-8.6%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.